Ninety One UK Ltd Has $275.17 Million Stock Holdings in Zoetis Inc. (NYSE:ZTS)

Ninety One UK Ltd boosted its stake in Zoetis Inc. (NYSE:ZTS) by 0.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,688,891 shares of the company’s stock after buying an additional 12,314 shares during the quarter. Ninety One UK Ltd owned approximately 0.37% of Zoetis worth $275,171,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of ZTS. Mizuho Securities USA LLC raised its stake in shares of Zoetis by 13,726.9% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,865,000 shares of the company’s stock worth $950,524,000 after purchasing an additional 4,829,815 shares in the last quarter. International Assets Investment Management LLC grew its stake in shares of Zoetis by 41,235.7% in the 3rd quarter. International Assets Investment Management LLC now owns 939,974 shares of the company’s stock valued at $183,652,000 after buying an additional 937,700 shares in the last quarter. Assenagon Asset Management S.A. increased its holdings in Zoetis by 296.9% in the fourth quarter. Assenagon Asset Management S.A. now owns 889,444 shares of the company’s stock worth $144,917,000 after buying an additional 665,331 shares during the last quarter. Nordea Investment Management AB raised its position in Zoetis by 38.3% during the fourth quarter. Nordea Investment Management AB now owns 2,065,514 shares of the company’s stock valued at $336,266,000 after acquiring an additional 572,511 shares in the last quarter. Finally, Holocene Advisors LP acquired a new stake in Zoetis in the third quarter valued at approximately $110,809,000. Institutional investors and hedge funds own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

ZTS has been the topic of several analyst reports. Leerink Partnrs upgraded shares of Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. JPMorgan Chase & Co. upped their price target on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Stifel Nicolaus lowered their price objective on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. UBS Group assumed coverage on Zoetis in a research note on Monday, December 9th. They set a “neutral” rating and a $196.00 price target on the stock. Finally, Morgan Stanley lowered their price target on shares of Zoetis from $248.00 to $243.00 and set an “overweight” rating on the stock in a report on Wednesday, January 29th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, Zoetis has a consensus rating of “Buy” and an average target price of $215.00.

Zoetis Trading Up 0.2 %

Shares of ZTS opened at $172.24 on Wednesday. The stock’s fifty day simple moving average is $169.48 and its 200-day simple moving average is $179.39. The firm has a market capitalization of $77.71 billion, a PE ratio of 32.38, a price-to-earnings-growth ratio of 2.72 and a beta of 0.90. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $200.53. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26.

Zoetis (NYSE:ZTS) last released its earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The company had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.29 billion. During the same period in the prior year, the company posted $1.36 EPS. The company’s revenue was up 11.6% compared to the same quarter last year. As a group, research analysts predict that Zoetis Inc. will post 5.9 earnings per share for the current year.

Zoetis Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 4th. Shareholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This is a boost from Zoetis’s previous quarterly dividend of $0.43. This represents a $2.00 dividend on an annualized basis and a yield of 1.16%. Zoetis’s dividend payout ratio (DPR) is presently 37.59%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.